Literature DB >> 33525662

Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer.

Giorgia Mori1, Maria Rosalia Pasca1.   

Abstract

Colorectal cancer (CRC) is the fourth most common cause of cancer-related death and the third most common cancer in the world. Depending on the origin of the mutation, colorectal carcinomas are classified as sporadic or hereditary. Cancers derived from mutations appearing during life, affecting individual cells and their descendants, are called sporadic and account for almost 95% of the CRCs. Less than 5% of CRC cases result from constitutional mutations conferring a very high risk of developing cancer. Screening for hereditary-related cancers is offered to individuals at risk for hereditary CRC, who have either not undergone genetic evaluation or have uncertain genetic test results. In this review, we briefly summarize the main findings on the correlation between sporadic CRC and the gut microbiota, and we specifically focus on the few evidences about the role that gut microorganisms have on the development of CRC hereditary syndromes. The characterization of a gut microbiota associated with an increased risk of developing CRC could have a profound impact for prevention purposes. We also discuss the potential role of the gut microbiota as therapeutic treatment.

Entities:  

Keywords:  Lynch syndrome; colorectal cancer; gut microbiota; hereditary colorectal cancer; microbial biomarkers

Year:  2021        PMID: 33525662      PMCID: PMC7865401          DOI: 10.3390/ijms22031312

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  168 in total

Review 1.  A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects.

Authors:  Harold Tjalsma; Annemarie Boleij; Julian R Marchesi; Bas E Dutilh
Journal:  Nat Rev Microbiol       Date:  2012-06-25       Impact factor: 60.633

2.  The human gut bacterial genotoxin colibactin alkylates DNA.

Authors:  Matthew R Wilson; Yindi Jiang; Peter W Villalta; Alessia Stornetta; Paul D Boudreau; Andrea Carrá; Caitlin A Brennan; Eunyoung Chun; Lizzie Ngo; Leona D Samson; Bevin P Engelward; Wendy S Garrett; Silvia Balbo; Emily P Balskus
Journal:  Science       Date:  2019-02-15       Impact factor: 47.728

3.  Gut microbiome development along the colorectal adenoma-carcinoma sequence.

Authors:  Qiang Feng; Suisha Liang; Huijue Jia; Andreas Stadlmayr; Longqing Tang; Zhou Lan; Dongya Zhang; Huihua Xia; Xiaoying Xu; Zhuye Jie; Lili Su; Xiaoping Li; Xin Li; Junhua Li; Liang Xiao; Ursula Huber-Schönauer; David Niederseer; Xun Xu; Jumana Yousuf Al-Aama; Huanming Yang; Jian Wang; Karsten Kristiansen; Manimozhiyan Arumugam; Herbert Tilg; Christian Datz; Jun Wang
Journal:  Nat Commun       Date:  2015-03-11       Impact factor: 14.919

Review 4.  Primary prevention of colorectal cancer.

Authors:  Andrew T Chan; Edward L Giovannucci
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

Review 5.  Probiotic use in clinical practice: what are the risks?

Authors:  Robert J Boyle; Roy M Robins-Browne; Mimi L K Tang
Journal:  Am J Clin Nutr       Date:  2006-06       Impact factor: 7.045

6.  Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis.

Authors:  Pieter Friederich; Jelle Verschuur; Bjorn W H van Heumen; Hennie M J Roelofs; Marloes Berkhout; Iris D Nagtegaal; Martijn G H van Oijen; Johannes H J M van Krieken; Wilbert H M Peters; Fokko M Nagengast
Journal:  Int J Colorectal Dis       Date:  2011-01-18       Impact factor: 2.571

7.  Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment.

Authors:  Michael B Burns; Emmanuel Montassier; Juan Abrahante; Sambhawa Priya; David E Niccum; Alexander Khoruts; Timothy K Starr; Dan Knights; Ran Blekhman
Journal:  PLoS Genet       Date:  2018-06-20       Impact factor: 5.917

8.  Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review.

Authors:  Hanna Fjeldheim Dale; Stella Hellgren Rasmussen; Özgün Ömer Asiller; Gülen Arslan Lied
Journal:  Nutrients       Date:  2019-09-02       Impact factor: 5.717

9.  Contribution of New Adenomatous Polyposis Predisposition Genes in an Unexplained Attenuated Spanish Cohort by Multigene Panel Testing.

Authors:  Víctor Lorca; Daniel Rueda; Lorena Martín-Morales; María Jesús Fernández-Aceñero; Judith Grolleman; Carmen Poves; Patricia Llovet; Sandra Tapial; Vanesa García-Barberán; Julián Sanz; Pedro Pérez-Segura; Richarda M de Voer; Eduardo Díaz-Rubio; Miguel de la Hoya; Trinidad Caldés; Pilar Garre
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

10.  Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer.

Authors:  Maelle Prorok-Hamon; Melissa K Friswell; Abdullah Alswied; Carol L Roberts; Fei Song; Paul K Flanagan; Paul Knight; Caroline Codling; Julian R Marchesi; Craig Winstanley; Neil Hall; Jonathan M Rhodes; Barry J Campbell
Journal:  Gut       Date:  2013-07-11       Impact factor: 23.059

View more
  3 in total

Review 1.  An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential.

Authors:  Małgorzata Guz; Witold Jeleniewicz; Marek Cybulski
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

Review 2.  Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI.

Authors:  Simona-Ruxandra Volovat; Iolanda Augustin; Daniela Zob; Diana Boboc; Florin Amurariti; Constantin Volovat; Cipriana Stefanescu; Cati Raluca Stolniceanu; Manuela Ciocoiu; Eduard Alexandru Dumitras; Mihai Danciu; Delia Gabriela Ciobanu Apostol; Vasile Drug; Sinziana Al Shurbaji; Lucia-Georgiana Coca; Florin Leon; Adrian Iftene; Paul-Corneliu Herghelegiu
Journal:  Cancers (Basel)       Date:  2022-10-03       Impact factor: 6.575

Review 3.  Bacterial Involvement in Progression and Metastasis of Adenocarcinoma of the Stomach.

Authors:  Amanda D Morgan; Kevin D Seely; Lauren D Hagenstein; Garrett M Florey; James M Small
Journal:  Cancers (Basel)       Date:  2022-10-06       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.